Author: Rimmerman Neta
Publisher: Springer Publishing Company
ISSN: 0272-4340
Source: Cellular and Molecular Neurobiology, Vol.31, Iss.6, 2011-08, pp. : 921-930
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Cannabidiol (CBD) is a non-psychoactive plant cannabinoid that is clinically used in a 1:1 mixture with the psychoactive cannabinoid Δ9-tetrahydrocannabinol (THC) for the treatment of neuropathic pain and spasticity in multiple sclerosis. Our group previously reported that CBD exerts anti-inflammatory effects on microglial cells. In addition, we found that CBD treatment increases the accumulation of the endocannabinoid
Related content
By Chen Jin-Cherng Liu Kris Sun Yang Ting-Ju Hwang Juen-Haur Chan Yin-Ching Lee I-Te
Nutritional Neuroscience, Vol. 15, Iss. 6, 2012-11 ,pp. :
Association study of cholesterol-related genes in Alzheimer's disease
By Wollmer M. Sleegers Kristel Ingelsson Martin Zekanowski Cezary Brouwers Nathalie Maruszak Aleksandra Brunner Fabienne Huynh Kim-Dung Kilander Lena Brundin Rose-Marie Hedlund Marie Giedraitis Vilmantas Glaser Anna Engelborghs Sebastiaan Deyn Peter Kapaki Elisabeth Tsolaki Magdalini Daniilidou Makrina Molyva Dimitra Paraskevas George Thal Dietmar Barcikowska Maria Kuznicki Jacek Lannfelt Lars Broeckhoven Christine Nitsch Roger Hock Christoph Papassotiropoulos Andreas
Neurogenetics, Vol. 8, Iss. 3, 2007-08 ,pp. :
Towards a transcriptome definition of microglial cells
By Moran L. Duke D. Turkheimer F. Banati R. Graeber M.
Neurogenetics, Vol. 5, Iss. 2, 2004-06 ,pp. :